Azamian Bobak R. sold 10,000 shares of Tarsus Pharmaceuticals, Inc. at $80.31 for −$803k on Nov 13, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President/CEO and Board Chair
President/CEO and Board Chair
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$803,100Shares × reported price
Shares traded
10,000Common Stock
Price per share
$80.31Reported price. Read footnotes for ranges.
% of reported position traded
1.21%This security and ownership context
Holdings after
817,991Indirect · By the Bobak Azamian Living Trust established April 16, 2018
Trade date
Nov 13, 2026Sell
Filed
Nov 17, 2026, 7:00 PM ET5-day reporting delay
Accession
0001827672-26-000016Code S · Transaction 404671
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 827,991 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

TARS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TARS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −7.6%1w ago −12%1d ago −1.7%
Returns since7d30d90d180d1y

Footnotes in full

F1: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F2: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.00 to $80.56. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.